FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/05/087380 [Registered on: 22/05/2025] Trial Registered Prospectively
Last Modified On: 09/05/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Behavioral 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Can educating parents or caregivers improve the health and medication routine of children with nephrotic syndrome? 
Scientific Title of Study   Impact of Caregiver Empowerment Module on the Quality of Life and Medication Adherence in the Children with Idiopathic Nephrotic Syndrome 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  JYOTI SHUKLA 
Designation  Nursing Officer 
Affiliation  Kalawati Saran Children Hospital 
Address  Nephrology ward Kalawati Saran Children Hospital Bangla Sahib Marg New Delhi

Central
DELHI
110001
India 
Phone  9868047765  
Fax    
Email  jyoti_shukla1984@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Abhijeet Saha 
Designation  Director Professor 
Affiliation  LHMC and KSCH 
Address  Division of Paediatric Nephrology Department of Pediatrics, LHMC and KSCH,New Delhi

Central
DELHI
110001
India 
Phone  9711007064  
Fax    
Email  drabhijeetsaha@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  DrAnita Gupta  
Designation  Professor 
Affiliation  Chitkara University 
Address  Chitkara School of Health Science Chitkara University

Patiala
PUNJAB
140401
India 
Phone  9876054823  
Fax    
Email  anita.gupta@chitkara.edu.in  
 
Source of Monetary or Material Support  
Kalawati Saran Children Hospital 
 
Primary Sponsor  
Name  Jyoti shukla 
Address  Kalawati Saran Children Hospital New Delhi 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrAbhijeet Saha  Kalawati saran Children Hospital  Nephrology OPD Kalawati saran Children Hospital Bangla Sahib Marg New Delhi
Central
DELHI 
9711007064

drabhijeetsaha@yahoo.com  
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee,Lady Hardinge Medical College and Associated Hospitals   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N040||Nephrotic syndrome with minor glomerular abnormality,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Caregiver Empowerment Module  A structured educational intervention (Caregiver Empowerment Module) delivered in four sessions over 2 months for caregivers of children with nephrotic syndrome. It includes a printed booklet covering illness, treatment, complications, medication and dietary adherence, urine dipstick testing, early relapse identification, and use of a medication diary. Sessions will be supported by PowerPoint presentations, demonstrations, and discussions. Fortnightly telephonic follow-up continues for six months to reinforce knowledge and caregiver support. 
Comparator Agent  routine care  Caregivers in the control group receive routine care provided by the hospital for children with nephrotic syndrome. No additional educational sessions or materials are given. 
 
Inclusion Criteria  
Age From  2.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  Children with SSNS including Frequently Relapsing Nephrotic Syndrome (FRNS), Infrequent Relapsing Nephrotic syndrome (IFRNS), Steroid Dependence Nephrotic Syndrome (SDNS) and their primary caregivers
those who can understand hindi or english language 
 
ExclusionCriteria 
Details  Children with Steroid resistant Nephrotic Syndrome (SRNS), congenital Nephrotic syndrome, Secondary Nephrotic syndrome and their caregivers  
 
Method of Generating Random Sequence   Permuted block randomization, variable 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1. Change in quality of life of children with idiopathic nephrotic syndrome (INS), measured using a pediatric quality of life questionnaire.
2. Change in medication adherence in children with idiopathic Nephrotic Syndrome, assessed using Morisky Medication Adherence Scale  
3 months and 6 months after completion of Caregiver Empowerment Module 
 
Secondary Outcome  
Outcome  TimePoints 
Change in the knowledge and practice scores of the caregivers of the children with nephrotic syndrome  3 months and 6 months after completion of Caregiver Empowerment module 
correlation between medication adherence and Quality of Life in children with nephrotic syndrome  3 months and 6 months after completion of Caregiver Empowerment module 
Association of quality of life and medication adherence with selected demographic and clinical variables.  3 months and 6 months after completion of the Caregiver Empowerment Module 
Time to first relapse after enrollment during the study period.  continously monitored for 6 months following completion of caregiver Empowerment Module  
Time of initiation of Prednisolone therapy at
60 mg/m²/day following relapse during study period 
continously monitored for 6 months following completion of caregiver Empowerment Module 
 
Target Sample Size   Total Sample Size="112"
Sample Size from India="112" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   03/06/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="10"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The randomized controlled trial aims to evaluate the impact of the Caregiver Empowerment Module on the quality of life and medication adherence among children (aged 2–12 years) diagnosed with steroid-sensitive nephrotic syndrome (SSNS), including frequently relapsing, infrequently relapsing, and steroid-dependent cases. The intervention group caregivers will receive a structured educational module comprising a booklet, PowerPoint presentations, demonstrations, and discussions delivered in four sessions over 2 months, followed by fortnightly telephonic follow-up for six months. The module includes disease understanding, treatment adherence, urine dipstick monitoring, relapse identification, and diary maintenance. The control group will receive routine care. Outcomes will be assessed at baseline, 3 months, and 6 months. In addition to quality of life and medication adherence, secondary outcomes include caregiver knowledge and practice, time to first relapse, and time to initiation of prednisolone therapy after relapse. The study will also examine correlations and associations between adherence, quality of life, and selected demographic and clinical variables. 
Close